SCHEMBL7130423

SCHEMBL7130423

CCNC(=O)Nc1ccc(Sc2ccc(S(=O)(=O)CC(CC(=O)O)c3ccccc3)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RORC P51449 2/20 0.44
MMP13 P45452 5/20 0.43
DHODH Q02127 1/20 0.43
MMP2 P08253 1/20 0.43
MMP8 P22894 1/20 0.43
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 1/20 0.41
SCN3A Q9NY46 1/20 0.40
FNTA P49354 2/20 0.39
FNTB P49356 2/20 0.39
NAMPT P43490 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7078041 0.91 RORC (0.47) RORCDHODHMMP2MMP8ALDH1A1
SCHEMBL7078046 0.89 DHODH (0.42) RORCMMP13DHODHMMP2MMP8
SCHEMBL7078136 0.88 MMP2 (0.58) DHODHMMP2MMP8FNTAFNTB
SCHEMBL8360105 0.87 RORC (0.43) RORCDHODHMMP2MMP8ALDH1A1
SCHEMBL7078388 0.82 NAMPT (0.44) LMNANAMPTCYP2C9
SCHEMBL7080988 0.81 ITGB3 (0.44) RORCALDH1A1LMNANPC1MAPT
SCHEMBL7077549 0.80 DHODH (0.44) RORCDHODHMMP2MMP8ALDH1A1
SCHEMBL7078927 0.76 CA12 (0.44) MMP13MMP2ALDH1A1LMNAMAPT
SCHEMBL7132373 0.75 SCN1A (0.46) MMP13ALDH1A1LMNAMAPTRAB9A
SCHEMBL11772950 0.75 DHODH (0.50) DHODHMMP2MMP8ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003059872-A1 AVB3 AND AVB5 INTEGRIN ANTAGONISTS AND METHODS OF TREATING DISEASES OR CONDITIONS ASSOCIATED WITH AVB3 AND AVB5 INTEGRINS BAYER PHARMACEUTICALS CORPORATION (US) 2003-07-24 WO disclosed